Venclexta (Venetoclax) for Lymphoma | MyLymphomaTeam

Connect with others who understand.

sign up Log in
About MyLymphomaTeam
Powered By

Venclexta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and adults over 75 years old with newly diagnosed acute myeloid lymphoma (AML). Venclexta is also referred to by its drug name, venetoclax.

Venclexta is used as targeted therapy for lymphoma. Venclexta is a member of a class of drugs called BCL-2 inhibitors. Venclexta is believed to work by binding to the BCL-2 protein which leads to the destruction of cancer cells.

How do I take it?
Prescribing information states that Venclexta should be taken orally once daily.

Venclexta comes in tablet form.

Side effects
The FDA-approved label for Venclexta lists common side effects including nausea, diarrhea, constipation, fever, fatigue, vomiting, swelling, pneumonia, hemorrhage, low blood count, rash, abdominal pain, infection, musculoskeletal pain, dizziness, cough, and low blood pressure.

Rare but serious side effects listed for Venclexta include low white blood cell counts and serious infections.

For more details about this treatment, visit:

Venclexta — Genentech/AbbVie

Venclexta — RxList

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in